Synthesis of Polyketides and Terpenes
聚酮化合物和萜烯的合成
基本信息
- 批准号:7847436
- 负责人:
- 金额:$ 42.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-05 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxybutanalAddressAntibioticsAntineoplastic AgentsBiologicalBiological FactorsBiologyCarbonChemicalsComplexConceptionsCouplingDevelopmentDisciplineEvaluationEventFamilyGoalsGrantHallucinogensIntentionMedicineMethodologyOrganic SynthesisPeptide FragmentsPeptide SynthesisPhorbolPhorbolsPolynucleotidesProcessPsychotropic DrugsReactionResearchSeriesStructureTarsTechnologyTerpenesTerramycinTetracyclinesTumor Promotersaflastatin Aamphidinol 3analogchemical reactionchemical synthesischemotherapeutic agentclinically significantcytotoxicdesigndrug candidatedrug discoveryenolateimprovedinnovationmarine natural productnew technologynovel strategiespeloruside Apolysaccharide peptidepredictive modelingsalvinorin Atool
项目摘要
DESCRIPTION (provided by applicant): The objectives of this ongoing proposed research are to make creative contributions to the synthesis of complex naturally occurring substances possessing clinically significant biological activity. This grant will continue to develop new stereoselective reactions and the application of this methodology to the asymmetric synthesis of complex polyketide antibiotics and antineoplastic agents. The synthesis targets will include amphinidinol 3, aflastatin 3, (+) peloruside A, salvinorin A, phorbol, and the tetracycline family of antibiotics. An important new approach in the synthesis of polycyclic structures from acyclic precursors has been illustrated in the design of salvinorin A, phorbol, and tetracycline. All of these syntheses begin with bond constructions that are stereochemically regulated by acyclic stereocontrol. The carbon framework is then assembled by a series of intramolecular, transannular processes from medium-ring macrocycles. Along with polynucleotides, peptides, and polysaccharides, polyketides represent the fourth broad family of naturally occurring materials that are assembled from common subunits. In extending the comparison with peptide synthesis, polyketide assembly through complex aldol bond constructions is a far greater challenge that the analogous peptide fragment assembly analogy since up to two new stereocenters are created during the fragment coupling event. Our long term objective in this grant has been the development of all of the methodology to assemble polyketide-derived natural products. This objective includes the development of chiral enolate methodology, the study of remote stereocenters on carbonyl and enolate pi-face selectivities, and the development of predictive models for double stereodifferentiating aldol addition reactions. The goal is to improve reaction design predictability. The polyketide targets are amphidinol A, aflastatin 3, peloruside, and salvinorin A. Chemical synthesis provides the capacity to produce chemotherapeutic agents, and chemical reactions are the irreplaceable tools of the medicinal chemist engaged in the drug discovery process. Advances in chemical reaction technology reduce the interval between the conception of the chemical entity as a potential drug candidate and its synthesis for subsequent biological evaluation. As a consequence, organic synthesis is a critical discipline that continues to have an important impact on the fields of both medicine and biology.
描述(由申请人提供):这项正在进行的拟议研究的目标是对具有临床显著生物活性的复杂天然存在物质的合成做出创造性贡献。这笔拨款将继续发展新的立体选择反应,并将这种方法应用于复杂的聚酮类抗生素和抗肿瘤药物的不对称合成。合成的靶点将包括amphinidinol 3、aflastatin 3、(+)peloruside A、salvinorin A、phorbol和四环素家族抗生素。从无环前体合成多环结构的一个重要的新方法已经在salvinorin A, phorbol和四环素的设计中得到了说明。所有这些合成都是从由非环立体控制的立体化学调节的键结构开始的。然后,碳骨架通过一系列分子内、跨环过程从中环大环组装。与多核苷酸、多肽和多糖一起,多酮类化合物代表了由共同亚基组装而成的第四大类天然物质。在扩展与肽合成的比较中,通过复杂的醛醇键构建聚酮组装比类似的肽片段组装类比更具挑战性,因为在片段偶联事件中产生了多达两个新的立体中心。我们在这笔拨款中的长期目标是开发所有组装聚酮衍生天然产品的方法。这一目标包括手性烯醇酯方法学的发展,羰基和烯醇酯远端立体中心选择性的研究,以及双立体分化醛醇加成反应的预测模型的发展。目标是提高反应设计的可预测性。聚酮靶点是两性酚A、黄萎病素3、佩洛苷和salvinorin A。化学合成提供了生产化疗药物的能力,化学反应是药物化学家在药物发现过程中不可替代的工具。化学反应技术的进步缩短了从化学实体作为潜在候选药物的概念到随后进行生物学评价的合成之间的间隔。因此,有机合成是一门关键学科,继续对医学和生物学领域产生重要影响。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A macrocyclic approach to tetracycline natural products. Investigation of transannular alkylations and Michael additions.
- DOI:10.1021/ol302691j
- 发表时间:2012-11
- 期刊:
- 影响因子:5.2
- 作者:J. Wzorek;Thomas F Knöpfel;Ioannis Sapountzis;D. A. Evans
- 通讯作者:J. Wzorek;Thomas F Knöpfel;Ioannis Sapountzis;D. A. Evans
Total synthesis of (+)-azaspiracid-1. An exhibition of the intricacies of complex molecule synthesis.
- DOI:10.1021/ja804659n
- 发表时间:2008-12-03
- 期刊:
- 影响因子:15
- 作者:Evans, David A.;Kvaerno, Lisbet;Dunn, Travis B.;Beauchemin, Andre;Raymer, Brian;Mulder, Jason A.;Olhava, Edward J.;Juhl, Martin;Kagechika, Katsuji;Favor, David A.
- 通讯作者:Favor, David A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David A Evans其他文献
The Brain Health Imperative in the 21st Century—A Call to Action
21 世纪的大脑健康势在必行——行动呼吁
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:9.9
- 作者:
Natalia S. Rost;J. Salinas;Justin T Jordan;Brenda L. Banwell;D. J. Correa;Rana R Said;Linda M Selwa;Sarah Song;David A Evans - 通讯作者:
David A Evans
David A Evans的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David A Evans', 18)}}的其他基金
ASYMMETRIC SYNTHESIS OF VANCOMYCIN ANTIBIOTICS
万古霉素类抗生素的不对称合成
- 批准号:
2182271 - 财政年份:1990
- 资助金额:
$ 42.41万 - 项目类别:
ASYMMETRIC SYNTHESIS OF VANCOMYCIN ANTIBIOTICS
万古霉素类抗生素的不对称合成
- 批准号:
2182270 - 财政年份:1990
- 资助金额:
$ 42.41万 - 项目类别:
ASYMMETRIC SYNTHESIS OF VANCOMYCIN ANTIBIOTICS
万古霉素类抗生素的不对称合成
- 批准号:
2392111 - 财政年份:1990
- 资助金额:
$ 42.41万 - 项目类别:
ASYMMETRIC SYNTHESIS OF VANCOMYCIN ANTIBIOTICS
万古霉素类抗生素的不对称合成
- 批准号:
2610695 - 财政年份:1990
- 资助金额:
$ 42.41万 - 项目类别:
ASYMMETRIC SYNTHESIS OF VANCOMYCIN ANTIBIOTICS
万古霉素类抗生素的不对称合成
- 批准号:
3303033 - 财政年份:1990
- 资助金额:
$ 42.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42.41万 - 项目类别:
Research Grant